Avian Influenza - The next travel-associated pandemic? Proactive One Health surveillance is required to reduce the risk of the spread.

Travel Med Infect Dis

Centre for Clinical Microbiology, Division of Infection and Immunity, University College London; and University College London Hospitals NHS Foundation Trust, London, United Kingdom; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address:

Published: February 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2025.102829DOI Listing

Publication Analysis

Top Keywords

avian influenza
4
influenza travel-associated
4
travel-associated pandemic?
4
pandemic? proactive
4
proactive health
4
health surveillance
4
surveillance required
4
required reduce
4
reduce risk
4
risk spread
4

Similar Publications

Cases of high-consequence infectious diseases identified in the UK, 1962-2023.

J Med Microbiol

March 2025

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, UK.

The management of patients with acute infectious diseases can present significant challenges, especially if the causative agent has a propensity for person-to-person transmission. In such cases, effective patient management is dependent on both rapid identification of disease and the provision of necessary medical care while adhering to suitable infection prevention and control measures to reduce the potential for onwards transmission. The UK has operated a defined system for managing patients with high-consequence infectious diseases (HCIDs) since the 1970s, when protocols were first implemented following the first descriptions of several viral haemorrhagic fever diseases, including Marburg virus disease, Lassa fever and Ebola virus disease (EVD).

View Article and Find Full Text PDF

The first highly pathogenic H5N1 emerged in 1959 on a chicken farm in Scotland. The ancestor of the strains presently circulating was isolated in 1996 from a domestic goose in China. Since 1997, more than 900 severe human infections have been reported.

View Article and Find Full Text PDF

Emergence of a novel reassortant H3N3 avian influenza virus with enhanced pathogenicity and transmissibility in chickens in China.

Vet Res

March 2025

Fujian Province Joint Laboratory of Animal Pathogen Prevention and Control of the "Belt and Road", College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, 350002, Fujian, China.

H3N3 avian influenza viruses (AIVs) are less prevalent in poultry than H3N8 viruses. However, although relatively rare, reassortant H3N3 viruses have been known to appear in both domestic poultry and wild birds. In this study, we isolated the H3N3 virus in chickens sourced from a live poultry market in China.

View Article and Find Full Text PDF

Avian influenza virus (AIV) currently causes a panzootic with extensive mortality in wild birds, poultry, and wild mammals, thus posing a major threat to global health and underscoring the need for efficient monitoring of its distribution and evolution. We here utilized a well-defined AIV strain to systematically investigate AIV genetic characterization through rapid, portable nanopore sequencing by comparing the latest DNA and RNA nanopore sequencing approaches and various computational pipelines for viral consensus sequence generation and phylogenetic analysis. We show that the latest direct RNA nanopore sequencing updates improve consensus sequence generation, but that the application of the latest DNA nanopore chemistry after reverse transcription and amplification outperforms, such native viral RNA sequencing by achieving higher sequencing accuracy and throughput.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!